retatrutide clinical trial weight loss Retatrutide: What It Is & How This New Drug Works Eli Lilly infiltrates anti-obesity market
Description
The SELECT trial demonstrated that semaglutide reduced major adverse cardiovascular events (heart attack, stroke, cardiovascular death) by 20 percent in overweight and obese adults with established cardiovascular disease
Yes, when prescribed and monitored by a physician
The gastrointestinal tract and glucose tolerance
(2025) (Open Access)
Evidence suggests that flexible dietary restraint, as opposed to rigid approaches, can support effective binge-eating control and weight management in patients with BED
